Predicted protein targets (top 2)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KISS1R | Q969F8 | 19/20 | 0.57 |
| ▸ | IL23R | Q5VWK5 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29595208 | 0.94 | KISS1R (0.62) | KISS1R | |
| SCHEMBL29595776 | 0.94 | KISS1R (0.62) | KISS1R | |
| SCHEMBL30450426 | 0.93 | KISS1R (0.63) | KISS1RIL23R | |
| SCHEMBL30675548 | 0.91 | KISS1R (0.64) | KISS1R | |
| SCHEMBL30802584 | 0.90 | KISS1R (0.63) | KISS1R | |
| SCHEMBL18082492 | 0.90 | KISS1R (0.56) | KISS1RIL23R | |
| SCHEMBL19842025 | 0.89 | KISS1R (0.60) | KISS1RIL23R | |
| SCHEMBL20376297 | 0.89 | KISS1R (0.60) | KISS1RIL23R | |
| SCHEMBL20376152 | 0.89 | KISS1R (0.60) | KISS1RIL23R | |
| SCHEMBL19842010 | 0.89 | KISS1R (0.60) | KISS1RIL23R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210138090-A1 | uPAR targeting peptide for use in peroperative optical imaging of invasive cancer | FLUOGUIDE A/S (DK) | 2021-05-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210138090-A1 | uPAR targeting peptide for use in peroperative optical imaging of invasive cancer | PLAUR, PLAU, PLG | KISS1R 1748/4885IL23R 1405/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.